Chemotherapy in the elderly: Pharmacologic considerations Review uri icon

Overview

MeSH Major

  • Aging
  • Antineoplastic Agents
  • Neoplasms

abstract

  • Careful attention to the physiologic changes associated with aging, along with dose adjustments for end-organ dysfunction (eg, renal and hepatic), is necessary to ensure the safe administration of antitumor chemotherapy to the elderly.

publication date

  • December 12, 2000

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 11088063

Additional Document Info

start page

  • 548

end page

  • 56

volume

  • 7

number

  • 6